Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianxin Lin

Showing results (171-180 of 237) with videos related to

Pageof 24
Sort By:
Signal Transduction and Targeted Therapy|July 9, 2025
Irinotecan alleviates chemoresistance to anthracyclines through the inhibition of AARS1-mediated BLM lactylation and homologous recombination repairXinyuan Li, Chunlin Zhang, Yuhua Mei, et al.
Clinical & Translational Immunology|April 16, 2024
Chitinase 3-like 1 expression associated with lymphatic metastasis and prognosis in urothelial carcinoma of the bladderBo Wang, Ke Chen, Mingchao Gao, et al.
Cancer Immunology Research|October 17, 2023
Effective Antitumor Immunity Can Be Triggered by Targeting VISTA in Combination with a TLR3-Specific AdjuvantBo Wang, Ziwei Ou, Wenlong Zhong, et al.
Journal for Immunotherapy of Cancer|April 8, 2024
Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responsesBo Wang, Bingkun Zhou, Junyu Chen, et al.
Biomedicines|June 26, 2025
Immune System Alterations in the Development of Three Urological Cancers: Insights from Large-Sample Mendelian RandomizationZhijian Chen, Ye Xie, Xiong Chen, et al.
Cancer Letters|January 4, 2021
Corrigendum to "Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM." [Canc. Lett. 449 (2019) 31-44]Ruihui Xie, Xu Chen, Ziyue Chen, et al.
Kidney International|June 15, 2021
A multicenter study to develop a non-invasive radiomic model to identify urinary infection stone in vivo using machine-learningJunjiong Zheng, Hao Yu, Jesur Batur, et al.
Journal of Cellular and Molecular Medicine|November 19, 2016
Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancerXu Chen, Peng Gu, Ruihui Xie, et al.
Small Methods|May 5, 2025
Identification of Multi-Landscape and Cell Interactions in the Tumor Microenvironment Through High-Coverage Single-Cell SequencingWenlong Zhong, Ligang Wang, Chengjunyu Zhang, et al.
Clinical and Translational Medicine|July 29, 2021
Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancerHanhao Zheng, Changhao Chen, Yuming Luo, et al.
Pageof 24

Showing results (171-180 of 237) with videos related to

Sort By:
Pageof 24
Signal Transduction and Targeted Therapy|July 9, 2025
Irinotecan alleviates chemoresistance to anthracyclines through the inhibition of AARS1-mediated BLM lactylation and homologous recombination repairXinyuan Li, Chunlin Zhang, Yuhua Mei, et al.
Clinical & Translational Immunology|April 16, 2024
Chitinase 3-like 1 expression associated with lymphatic metastasis and prognosis in urothelial carcinoma of the bladderBo Wang, Ke Chen, Mingchao Gao, et al.
Cancer Immunology Research|October 17, 2023
Effective Antitumor Immunity Can Be Triggered by Targeting VISTA in Combination with a TLR3-Specific AdjuvantBo Wang, Ziwei Ou, Wenlong Zhong, et al.
Journal for Immunotherapy of Cancer|April 8, 2024
Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responsesBo Wang, Bingkun Zhou, Junyu Chen, et al.
Biomedicines|June 26, 2025
Immune System Alterations in the Development of Three Urological Cancers: Insights from Large-Sample Mendelian RandomizationZhijian Chen, Ye Xie, Xiong Chen, et al.
Cancer Letters|January 4, 2021
Corrigendum to "Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM." [Canc. Lett. 449 (2019) 31-44]Ruihui Xie, Xu Chen, Ziyue Chen, et al.
Kidney International|June 15, 2021
A multicenter study to develop a non-invasive radiomic model to identify urinary infection stone in vivo using machine-learningJunjiong Zheng, Hao Yu, Jesur Batur, et al.
Journal of Cellular and Molecular Medicine|November 19, 2016
Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancerXu Chen, Peng Gu, Ruihui Xie, et al.
Small Methods|May 5, 2025
Identification of Multi-Landscape and Cell Interactions in the Tumor Microenvironment Through High-Coverage Single-Cell SequencingWenlong Zhong, Ligang Wang, Chengjunyu Zhang, et al.
Clinical and Translational Medicine|July 29, 2021
Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancerHanhao Zheng, Changhao Chen, Yuming Luo, et al.
Pageof 24